Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: q

Product Information Leaflets 1 - 27 of 27
SPC	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Qaialdo - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Qalsody - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Qarziba - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Qdenga - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: QINLOCK - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Qlaira tabletti, kalvopäällysteinen PL 2022-01-31
SPC	Resepti	Qsiva 3.75 mg-23 mg, 7.5 mg-46 mg, 11.25 mg-69 mg, 15 mg-92 mg säädellysti vapauttava kapseli, kova PL 2024-05-06
		European Medicines Agency's website: Qtern - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Qtern - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Quadramet - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Questran 4 g jauhe oraalisuspensiota varten Rx PL 2023-03-29.docx
SPC	Resepti	Questran jauhe PL 2018-11-30
SPC	Resepti	Quetiapin Hexal 50 mg, 150 mg, 200 mg, 300 mg, 400 mg depottabletti PL 2024-06-24
SPC	Resepti	Quetiapin Krka 50 mg, 200 mg, 300 mg, 400 mg depottabletti PL 2021-12-09
SPC	Resepti	Quetiapin Medical Valley 50 mg, 150 mg, 200 mg, 300 mg, 400 mg depottabletti PL 2023-06-13
SPC	Resepti	Quetiapin Orion 25 mg, 100 mg, 200 mg, 300 mg tabletti, kalvopäällysteinen PL 2024-07-01
SPC	Resepti	Quetiapin ratiopharm 50 mg, 200 mg, 300 mg, 400 mg depottabletti PL 2024-05-21
	Resepti	Quetiapine Accord 150 mg depottabletti PL 2021-07-01.doc
SPC	Resepti	Quetiapine Accord 150 mg depottabletti PL 2024-06-03
SPC	Resepti	Quetiapine Accord 25 mg, 100 mg, 200 mg, 300 mg tabletti, kalvopäällysteinen PL 2024-08-21
SPC	Resepti	Quetiapine Accord 50 mg, 200 mg, 300 mg, 400 mg depottabletti PL 2024-03-14
	Resepti	Quetiapine Accord 50, 200, 300, 400 mg depottabletti PL 2021-07-01.docx
SPC	Resepti	Quetiapine Teva 25 mg, 100 mg, 200 mg, 300 mg tabletti, kalvopäällysteinen PL 2024-05-24
		European Medicines Agency's website: Quinsair - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Quofenix - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Qutenza - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Quviviq - EMA: EPAR PI Finnish Swedish